학술논문

The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation
Document Type
Academic Journal
Source
Clinical Infectious Diseases. June 1, 2007, Vol. 44 Issue 11, p1475, 9 p.
Subject
Antiviral agents -- Dosage and administration
Antiviral agents -- Research
Pharmacokinetics -- Research
Drug therapy, Combination -- Research
Saquinavir -- Dosage and administration
Health
Health care industry
Language
English
ISSN
1058-4838